title: Rapid-infusion rituximab in lymphoma treatment.
authors.forename: M
authors.initials: M
authors.lastname: Provencio
authors.forename: S
authors.initials: S
authors.lastname: Cerdeira
authors.forename: F
authors.initials: F
authors.lastname: Bonilla
authors.forename: A
authors.initials: A
authors.lastname: Sánchez
authors.forename: P
authors.initials: P
authors.lastname: España
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab